TEG and Vascular Closure are doing - TEG is ... Look, I'm not sure I can do the Super Bowl analogy justice. When you think about Haemonetics and the investment thesis behind that, lots transpired ...

Ratings for Haemonetics HAE were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ...

Haemonetics Trading Up 3.4 % NYSE HAE opened at $71.26 on Thursday. Haemonetics has a one year low of $65.73 and a one year high of $97.97. The company has a debt-to-equity ratio of 1.39, a quick ...

BOSTON (AP) — BOSTON (AP) — Haemonetics Corp. (HAE) on Thursday reported fiscal third-quarter net income of $37.5 million. The Boston-based company said it had net income of 74 cents per share.

Haemonetics (HAE) came out with quarterly earnings of $1.19 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.04 per share a year ago. These figures are ...

Blood products company Haemonetics (NYSE:HAE). fell short of the market’s revenue expectations in Q4 CY2024 as sales rose 3.7% year on year to $348.5 million. Its non-GAAP profit of $1.19 per ...

HAEMONETICS ($HAE) posted quarterly earnings results on Thursday, February 6th. The company reported earnings of $1.19 per share, beating estimates of $1.18 by $0.01 ...